Inventor · disambiguated record
David William End
Also filed as: END DAVID WILLIAM
13 granted patents·8 pending applications·504 citations·filing 1996–2012
94Inventor score
Top patents by PatentIndex Score
21 records- 0195US5968952AFarnesyl transferase inhibiting 2-quinolone derivativesJANSSEN PHARMACEUTICA NV·Filed 1996·Granted Oct 19, 1999·95 cites·13 claims
- 0294US6734194B2Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 2003·Granted May 11, 2004·67 cites·7 claims
- 0393US6743805B2Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Jun 1, 2004·59 cites·5 claims
- 0491US6838467B2Dosing regimenJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Jan 4, 2005·56 cites·10 claims
- 0586US6451812B1Farnesyl protein transferase inhibitors for treating arthropathiesJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Sep 17, 2002·92 cites·11 claims
- 0685US8329714B2Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomerVENET MARC GASTON·Filed 2007·Granted Dec 11, 2012·7 cites·9 claims
- 0785US8318753B2Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomerVENET MARC GASTON·Filed 2007·Granted Nov 27, 2012·7 cites·3 claims
- 0884US7253183B2Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Aug 7, 2007·17 cites·8 claims
- 0980US6365600B1(Imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Apr 2, 2002·40 cites·8 claims
- 1076US7511061B2Triazoles as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Mar 31, 2009·2 cites·12 claims
- 1175US6545020B1Farnesyl Protein transferase inhibitors with in vivo radiosensitizing propertiesJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Apr 8, 2003·56 cites·15 claims
- 1268US7049324B1Triazoles as farnesyl transferase inhibitorsSAHA ASHIS KUMAR·Filed 2000·Granted May 23, 2006·6 cites·10 claims
- 1364US2009023776A1Farnesyl protein transferase inhibitor combinations with antiestrogen agentsEND DAVID WILLIAM·Filed 2008·Application pending·0 cites
- 1461US2011105557A1Farnesyl protein transferase inhibitor combinations with antiestrogen agentsEND DAVID WILLIAM·Filed 2011·Application pending·0 cites
- 1558US2004110769A1Farnesyl protein transferase inhibitor combinations with antiestrogen agentsFiled 2002·Application pending·0 cites
- 1657US7592356B2Triazoles as farnesyl transferase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 22, 2009·0 cites·10 claims
- 1756US2012108634A1Farnesyl protein transferase inhibitor combinations with antiestrogen agentsEND DAVID WILLIAM·Filed 2012·Application pending·0 cites
- 1851US2004157882A1Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferationFiled 2003·Application pending·0 cites
- 1949US2003114471A1Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomerFiled 2001·Application pending·0 cites
- 2048US2004157773A1Farnesyl protein transferase inhibitors for treating cachexiaFiled 2002·Application pending·0 cites
- 2138US2004044032A1Farnesyl protein transfer inhibitors for the treatment of inflammatory bowel diseaseFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David William End files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →